Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients

NCT06922045 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia

Interventions

DRUG: STSP-0601 for Injection

Sponsor

Jiangsu BioJeTay Biotechnology Co., Ltd.